BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
376.65
-0.21 (-0.06%)
Aug 20, 2026, 7:58 AM EDT - Market open

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20
BRUKINSA Revenue
1.25B
TEVIMBRA Revenue
228.52M
XGEVA Revenue
104.50M
BLINCYTO Revenue
36.54M
KYPROLIS Revenue
15.15M
POBEVCY Revenue
9.63M
Total Other Product Revenue
37.82M
Total Product Revenue
1.68B
Collaboration Revenue
25.28M
Revenue (Total)
1.71B

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20
U.S. Revenue
914.21M
China Revenue
506.02M
Europe Revenue
208.76M
Rest of World Revenue
76.09M
Rest of World Revenue (Pre-Q3 2022 Reporting)
284.85M
Revenue (Total)
1.71B